According to Sutro Biopharma's latest financial reports the company's current EPS (TTM) is -HK$19.15. In 2022 the company made an earnings per share (EPS) of -HK$18.38 a decrease over its 2021 EPS that were of -HK$17.76.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$19.36 | 5.35% |
2022 | -HK$18.38 | 3.49% |
2021 | -HK$17.76 | 78.91% |
2020 | -HK$9.92 | -47.11% |
2019 | -HK$18.76 | -12.2% |
2018 | -HK$21.37 |